Interaction between prostacyclin and molsidomine in blood cells and plasma.
Gryglewski
R J
RJ
Chair of Pharmacology, N. Copernicus Academy of Medicine, Cracow, Poland.
Bieroń
K
K
Dembińska-Kieć
A
A
Kostka-Trabka
E
E
Zembowicz
A
A
D000368:Aged; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D004357:Drug Synergism; D011464:Epoprostenol / Q000494:pharmacology*; D005343:Fibrinolytic Agents; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects*; D010949:Plasma / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects; D051381:Rats; D019820:Xanthine; D014969:Xanthine Oxidase / Q000378:metabolism; D014970:Xanthines / Q000494:pharmacology
D005343:Fibrinolytic Agents; D014970:Xanthines; D019820:Xanthine; D008981:Molsidomine; D011464:Epoprostenol; D014969:Xanthine Oxidase